Melinda Telli, MD, on Triple-Negative Breast Cancer: New Clinical Approaches

2017 San Antonio Breast Cancer Symposium
Tweet this page

Melinda Telli, MD, of the Stanford University School of Medicine, discusses the current status of treatment for advanced TNBC, and new therapeutic strategies now being used for better outcomes.

Advertisement

Advertisement



Advertisement